Arizona Alzheimer's Disease Research Center (ADRC)

Description

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.

Conditions

Alzheimer Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The Arizona Alzheimer's Disease Research Center (ADRC) is the National Institute on Aging's (NIA's) first statewide AD Center (ADC), the only ADC in the Southwestern United States, and a leading example of statewide collaboration in biomedical research. It capitalizes on Arizona's strengths in brain imaging, genomics, computer science and biomathematics, the basic, cognitive and behavioral neurosciences, clinical, and neuropathological studies of AD, the discovery and evaluation of investigational treatments, and the study of normal cognitive aging.

Arizona Alzheimer's Disease Research Center (ADRC)

Arizona Alzheimer's Disease Research Center (ADRC)

Condition
Alzheimer Disease
Intervention / Treatment

-

Contacts and Locations

Phoenix

Banner Alzheimer's Institute, Phoenix, Arizona, United States, 85006

Phoenix

Barrow Neurological Institute, Phoenix, Arizona, United States, 85013

Scottsdale

Mayo Clinic, Scottsdale, Arizona, United States, 85259

Sun City

Banner Sun Health Research Institute, Sun City, Arizona, United States, 85351

Tucson

Banner Alzheimer's Institute - Tucson, Tucson, Arizona, United States, 85718

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Cognitively normal persons, individuals with mild cognitive impairment or dementia who are at least 40 years of age.
  • * Willing to undergo health and cognitive assessments, and collection and banking of blood with venipuncture for genetic research, biomarker research, and DNA banking.
  • * 1. Participants whose diagnosis is unclear and confounded by multiple possible factors are excluded. Participants with diagnoses of non-AD dementias are not excluded.
  • 2. Participants whose primary diagnosis is cognitive impairment due to a penetrating or single severe closed head injury, multiple sclerosis, brain tumor, metabolic or toxic encephalopathy, post-infectious (e.g., viral encephalitis, bacterial meningitis), paraneoplastic, primary psychiatric illness, or otherwise not deemed relevant to the intent of the Alzheimer Disease Center program are excluded.
  • 3. Procedure specific exclusion criteria also apply but this does not impact the participants ability to be included in the study.

Ages Eligible for Study

40 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Banner Health,

Study Record Dates

2026-06-30